Strategic Partnerships Longeviti has established collaborations with Johns Hopkins and is actively partnering with Clarius Mobile Health, signaling openness to co-development and joint solutions that can be leveraged to expand product reach and integration opportunities with major medical institutions and imaging vendors.

Board Leadership Recent appointments of high-profile board members, including Tim Scannell as Chair and Robert W. Sharps as a director, indicate strengthened governance and strategic backing that can accelerate fundraising, scale capabilities, and enable introductions to potential customers and strategic investors.

Productize Imaging The ClearFit platform enables post-surgical ultrasound imaging and real-time data, presenting a compelling value proposition for neuro-surgical centers seeking integrated imaging and skull reconstruction solutions, with potential cross-sell to hospitals adopting advanced neurosurgical workflows.

Market Positioning With a focus on complex brain disorders and a modular intracranial platform, Longeviti sits among specialized medical device players and can pursue opportunities with mid-market neuro centers and large hospitals looking for niche, customizable neurosurgical hardware and imaging solutions.

Growth Signals A revenue range of 10–25 million, active press coverage, and ongoing industry presence at meetings like the North American Skull Base Society indicate momentum and a readiness to engage with new customers, distributors, and regional sales partners to accelerate adoption.